New combo aims to keep myeloma in check after CAR t
Disease control
Recruiting now
This study tests whether adding two drugs (elotuzumab and iberdomide) plus a steroid after CAR T-cell therapy can help control multiple myeloma that has come back or not responded to treatment. About 49 adults who have already tried at least four other treatments will take part. …
Phase: PHASE1, PHASE2 • Sponsor: Omar Nadeem, MD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC